BROKERS CHOICE: TATACONS, CITIUNION, AMBUJACEM, BHARTIAIR, SWIGGY, ETERNAL, NIVABUPA, TITAN, WESTLIFE

AHMEDABAD, 4 NOVEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

MS on Tata Consumer: Maintain Overweight on Company, raise target price at Rs 1265 (Positive)

GS on Tata Consumer: Maintain Buy on Company, raise target price at Rs 1350 (Positive)

Elara on Citi Union Bank: Maintain Buy on Bank, raise target price at Rs 275 (Positive)

Macquarie on Citi Union Bank: Maintain Outperform on Bank, target price at Rs 245 (Positive)

Elara on Ambuja Cement: Maintain Buy on Company, raise target price at Rs 647 (Positive)

HSBC on Ambuja Cement: Maintain Buy on Company, raise target price at Rs 700 (Positive)

CLSA on Ambuja Cement: Maintain Outperform on Company, target price at Rs 680 (Positive)

Citi on Bharti Airtel: Maintain Buy on Company, raise target price at Rs 2225 (Positive)

CLSA on Bharti Airtel: Maintain Outperform on Company, target price at Rs 2285 (Positive)

Jefferies on Bharti Airtel: Maintain Buy on Company, raise target price at Rs 2635 (Positive)

Bernstein on Swiggy: Initiate Outperform on Company, target price at Rs 570 (Positive)

Bernstein on Eternal: Initiate Outperform on Company, target price at Rs 390 (Positive)

Citi on Indus Tower: Maintain Buy on Company, target price at Rs 500 (Positive)

Nuvama on GE T&D: Maintain Buy on Company, raise target price at Rs 3680 (Positive)

Nuvama on ACC: Maintain Buy on Company, raise target price at Rs 2282 (Positive)

Nuvama on Ajanta Pharma: Maintain Buy on Company, raise target price at Rs 3250 (Positive)

BofA on India Strategy: Q2FY26: Modest earnings beat. Nifty earnings up by 7% ; led by Energy/Metals/Industrials (Positive)

Jefferies on India Strategy: Sep’25 Mid-Quarter Review – In line so far (Neutral)

Jefferies on Niva Bupa: Maintain Hold on Company, target price at Rs 81 (Neutral)

MS on Niva Bupa: Maintain Equal weight on Company, target price at Rs 81 (Neutral)

MS on Titan: Maintain Overweight on Company, target price at Rs 3953 (Neutral)

UBS on Titan: Maintain Hold on Company, target price at Rs 4700 (Neutral)

Jefferies on Ajanta Pharma: Maintain Buy on Company, cut target price at Rs 3120 (Neutral)

CLSA on Tata Consumer: Maintain Hold on Company, raise target price at Rs 1097 (Neutral)

Macquarie on Westlife: Maintain Outperform on Company, target price at Rs 750 (Neutral)

Elara on Westlife: Maintain Accumulate on Company, cut target price at Rs 640 (Neutral)

MS on Kansai Nerolac: Maintain Underweight on Company, target price at Rs 212 (Neutral)

CLSA on ACC: Maintain Hold on Company, target price at Rs 2035 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)